Relationship of Central Venous Pressure to Body Fluid Volume Status and Its Prognostic Implication in Patients With Acute Decompensated Heart Failure.
Taiki Sakaguchi, Akio Hirata, Kazunori Kashiwase...
https://pubmed.ncbi.nlm.nih.gov/29890212/Actively Recruiting
Led by Mid and South Essex NHS Foundation Trust · Updated on 2025-09-15
255
Participants Needed
1
Research Sites
30 weeks
Total Duration
This research aims to evaluate whether using Bioimpedance Analysis BIA can improve fluid management in patients hospitalized with worsening heart failure. The study compares BIA-guided treatment to standard care to see if this approach reduces the need for extra diuretic treatment or rehospitalization within 90 days after discharge. Heart failure affects millions worldwide, and managing fluid levels accurately is a key challenge in preventing hospital readmissions and worsening symptoms. Participants will be randomly assigned to one of two groups. The BIA-guided group will have BIA measurements performed within 24 hours of admission and throughout their hospital stay to guide fluid management and diuretic use. The standard care group will also have BIA measurements at admission and discharge, but these results will not be shared with their care team, who will manage fluid levels based on usual clinical assessments. After discharge, all patients will attend a follow-up visit 2 to 4 weeks later for health checks, blood tests including NT-proBNP, and a quality-of-life questionnaire. During the study, participants will undergo standard clinical exams, blood tests, and questionnaires to assess heart failure symptoms and quality of life. Researchers will track hospital readmissions, need for additional treatment, kidney function, length of hospital stay, and mortality up to 12 months after discharge. The main outcome is the rate of heart failure events within 90 days post discharge. Safety and long-term effects will also be monitored, with data analyzed after all participants have completed follow-up.
CONDITIONS
Bioimpedance Integration for Optimized Fluid Management in Decompensated Heart Failure
H
Henry Oluwasefunmi Savage, MD FRCP
A
Archana Ganapathy, MRCP
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Mid and South Essex NHS Foundation Trust
Lead Sponsor
Anglia Ruskin University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration of hospital stay up to 30 days
Participants hospitalized with acute decompensated heart failure receive fluid management guided by bioimpedance analysis or standard care during their hospital stay.
1 to 2 visits during hospital admission
Duration - 2 to 4 weeks post discharge
Participants are followed up 2 to 4 weeks after discharge to assess clinical status, biomarker levels, and quality of life using standard clinical assessments and questionnaires.
1 follow-up visit (in-person)
Duration - Up to 12 months post discharge
Participants are monitored for heart failure events, hospitalizations, and mortality up to 12 months after discharge.
Periodic assessments based on routine clinical care
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Taiki Sakaguchi, Akio Hirata, Kazunori Kashiwase...
https://pubmed.ncbi.nlm.nih.gov/29890212/Eloisa Colín-Ramírez, Lilia Castillo-Martínez, Arturo Orea-Tejeda...
https://pubmed.ncbi.nlm.nih.gov/22465907/Fernanda Donner Alves, Gabriela Corrêa Souza, Nadine Clausell...
https://pubmed.ncbi.nlm.nih.gov/27118274/Taiki Sakaguchi, Kaori Yasumura, Hiroki Nishida...
https://pubmed.ncbi.nlm.nih.gov/26477274/Angela Teodósio da Silva, Daniela Barbieri Hauschild, Luna Dias de Almeida Oliveira...
https://pubmed.ncbi.nlm.nih.gov/30390867/Simona Santarelli, Veronica Russo, Irene Lalle...
https://pubmed.ncbi.nlm.nih.gov/27073131/Kaitlin J Mayne, Richard Shemilt, David F Keane...
https://pubmed.ncbi.nlm.nih.gov/36038013/Salvatore Di Somma, Irene Lalle, Laura Magrini...
https://pubmed.ncbi.nlm.nih.gov/24477201/Michel Y Jaffrin, Hélène Morel
https://pubmed.ncbi.nlm.nih.gov/18676172/Salvatore Di Somma, Benedetta De Berardinis, Cristina Bongiovanni...
https://pubmed.ncbi.nlm.nih.gov/20653713/Mid and South Essex NHS Foundation Trust
Lead Sponsor
Anglia Ruskin University
Collaborating Sponsor